PRASCEND
@prascend.com
Prascend® (pergolide tablets) is the most proven treatment for pituitary pars intermedia dysfunction (PPID) in horses. With PRASCEND, every day counts.
PRASCEND's Company Logos
PRASCEND's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#7F3647
Solid Pink
127, 54, 71
346, 40, 35
0, 57, 44, 50
#CCFAE5
Scandal
204, 250, 229
153, 82, 89
18, 0, 8, 2
#151B17
Heavy Metal
21, 27, 23
140, 13, 9
22, 0, 15, 89
About PRASCEND
**Brand Description: Prascend**
Prascend, developed by Boehringer Ingelheim, is a leading treatment for horses diagnosed with Pituitary Pars Intermedia Dysfunction (PPID), commonly known as equine Cushing’s disease. This progressive neurodegenerative disorder affects the pituitary gland, disrupting normal bodily functions and leading to various clinical signs such as lethargy, decreased performance, and abnormal sweating. Prascend’s primary active ingredient, pergolide, effectively manages these symptoms and helps reduce the risk of associated conditions such as laminitis and insulin dysregulation.
In addition to pharmacological treatment, Prascend emphasizes the importance of comprehensive management strategies tailored to each horse's needs. This includes proper diet, regular exercise, and consistent veterinary care. The brand's mission extends beyond just treatment; it aims to enhance the understanding of endocrine disorders through collaboration with the Equine Endocrinology Group, thus improving diagnosis and management for horse owners and veterinarians alike. Prascend stands out not only for its proven efficacy but also for its commitment to equine health and welfare.
